Diabetes and Tuberculosis: a Review of the Role of Optimal Glycemic Control

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2013 Mar 19

PMID 23497638

Citations 49

Authors

Asfandyar Khan Niazi

Sanjay Kalra

Affiliations

Soon will be listed here.

Abstract

Developing countries shoulder most of the burden of diabetes and tuberculosis. These diseases often coexist. Suboptimal control of diabetes predisposes the patient to tuberculosis, and is one of the common causes of poor response to anti-tubercular treatment. Tuberculosis also affects diabetes by causing hyperglycemia and causing impaired glucose tolerance. Impaired glucose tolerance is one of the major risk factors for developing diabetes. The drugs used to treat tuberculosis (especially rifampicin and isoniazid) interact with oral anti-diabetic drugs and may lead to suboptimal glycemic control. Similarly some of the newer oral anti-diabetic drugs may interact with anti-tuberculosis drugs and lower their efficacy. Therefore diabetes and tuberculosis interact with each other at multiple levels - each exacerbating the other. Management of patients with concomitant tuberculosis and diabetes differs from that of either disease alone. This article reviews the association between diabetes and tuberculosis and suggests appropriate management for these conditions.

Citing Articles

Diabetes mellitus and its determinants among tuberculosis patients in South Gondar Zone health facilities, Northwest Ethiopia.

Damtie S, Legese B, Fentie A, Solomon Y, Erkihun M, Molla T Sci Rep. 2025; 15(1):5813.

PMID: 39962284 PMC: 11833058. DOI: 10.1038/s41598-025-90441-1.

Association Between Diabetes Mellitus-Tuberculosis and the Generation of Drug Resistance.

Cornejo-Baez A, Zenteno-Cuevas R, Luna-Herrera J Microorganisms. 2025; 12(12.

PMID: 39770852 PMC: 11728438. DOI: 10.3390/microorganisms12122649.

Cervical Tuberculous Lymphadenitis Associated With New-Onset Acanthosis Nigricans Following Antitubercular Therapy: A Case Report.

Meade J, Back W, Arif S, Georgescu C, Tang J, Ellis M Cureus. 2024; 16(7):e65012.

PMID: 39165464 PMC: 11333633. DOI: 10.7759/cureus.65012.

Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges.

Al-Bari M, Peake N, Eid N World J Diabetes. 2024; 15(5):853-866.

PMID: 38766427 PMC: 11099355. DOI: 10.4239/wjd.v15.i5.853.

Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study.

Oliveira Hashiguchi L, Ferrer J, Suzuki S, Faguer B, Solon J, Castro M PLOS Glob Public Health. 2024; 4(5):e0003156.

PMID: 38696522 PMC: 11065219. DOI: 10.1371/journal.pgph.0003156.

References

WINTERBAUER R, Bedon G, BALL Jr W . Recurrent pneumonia. Predisposing illness and clinical patterns in 158 patients. Ann Intern Med. 1969; 70(4):689-700. DOI: 10.7326/0003-4819-70-4-689. View

Restrepo B . Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis. 2007; 45(4):436-8. PMC: 2900315. DOI: 10.1086/519939. View

Alisjahbana B, Sahiratmadja E, Nelwan E, Purwa A, Ahmad Y, Ottenhoff T . The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007; 45(4):428-35. DOI: 10.1086/519841. View

Atkin S, Masson E, Bodmer C, Walker B, White M . Increased insulin requirement in a patient with type 1 diabetes on rifampicin. Diabet Med. 1993; 10(4):392. DOI: 10.1111/j.1464-5491.1993.tb00086.x. View

Rajalakshmi S, Veluchamy G . Yugi's pramegam and diebetes mellitus: an analogue. Bull Indian Inst Hist Med Hyderabad. 2003; 29(1):83-7. View

ENGELBACH K . [Transitory diabetes mellitus in two tuberculotics]. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1954; 110(5):470-3. View

Jeon C, Harries A, Baker M, Hart J, Kapur A, Lonnroth K . Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health. 2010; 15(11):1300-14. DOI: 10.1111/j.1365-3156.2010.02632.x. View

Geerlings S, Hoepelman A . Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999; 26(3-4):259-65. DOI: 10.1111/j.1574-695X.1999.tb01397.x. View

Nijland H, Ruslami R, Stalenhoef J, Nelwan E, Alisjahbana B, Nelwan R . Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis. 2006; 43(7):848-54. DOI: 10.1086/507543. View

10.

Rodbard H, Jellinger P, Davidson J, Einhorn D, Garber A, Grunberger G . Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009; 15(6):540-59. DOI: 10.4158/EP.15.6.540. View

11.

Stevenson C, Critchley J, Forouhi N, Roglic G, Williams B, Dye C . Diabetes and the risk of tuberculosis: a neglected threat to public health?. Chronic Illn. 2007; 3(3):228-45. DOI: 10.1177/1742395307081502. View

12.

NICHOLS G . Diabetes among young tuberculous patients; a review of the association of the two diseases. Am Rev Tuberc. 1957; 76(6):1016-30. DOI: 10.1164/artpd.1957.76.6.1016. View

13.

Swai A, McLarty D, Mugusi F . Tuberculosis in diabetic patients in Tanzania. Trop Doct. 1990; 20(4):147-50. DOI: 10.1177/004947559002000402. View

14.

Ruslami R, Aarnoutse R, Alisjahbana B, van der Ven A, van Crevel R . Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010; 15(11):1289-99. DOI: 10.1111/j.1365-3156.2010.02625.x. View

15.

Madsbad S . Treatment of type 2 diabetes with incretin-based therapies. Lancet. 2008; 373(9662):438-9. DOI: 10.1016/S0140-6736(08)61247-7. View

16.

Mugusi F, Swai A, Alberti K, McLarty D . Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle. 1990; 71(4):271-6. DOI: 10.1016/0041-3879(90)90040-f. View

17.

Sidibe E . [Pulmonary tuberculosis and diabetes: aspects of its epidemiology, pathophysiology, and symptoms]. Sante. 2007; 17(1):29-32. View

18.

Tsukaguchi K, Yoneda T, Yoshikawa M, Tokuyama T, Fu A, Tomoda K . [Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis]. Kekkaku. 1992; 67(12):755-60. View

19.

Jeon C, Murray M . Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7):e152. PMC: 2459204. DOI: 10.1371/journal.pmed.0050152. View